Merck & Co., Inc. (MRK) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD $2.83B; Long-term Debt, Excluding Current MaturitiesUSD $51.08B; Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD $2.44B; Long-term Debt, Excluding Current MaturitiesUSD $46.67B; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Debt, CurrentUSD $2.59B; Long-term Debt, Excluding Current MaturitiesUSD $46.75B; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $2.30B; Debt, CurrentUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-Term Debt, Maturity, Year OneUSD $2.60B.
Merck & Co., Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Debt, Current USD | Long-term Debt, Excluding Current Maturities USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Debt, Long-term and Short-term, Combined Amount USD | Debt Instrument, Fair Value Disclosure USD | Long-term Debt USD | Debt Instrument, Face Amount EUR | Debt Instrument, Face Amount USD | Debt Instrument, Repurchased Face Amount USD | Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate pure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.83B | $51.08B | (m) | (m) | (m) | (m) | (m) | (m) | $53.90B | $49.90B | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $2.44B | $46.67B | (m) | (m) | (m) | (m) | (m) | (m) | $49.10B | $44.70B | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $2.59B | $46.75B | (m) | (m) | (m) | (m) | (m) | (m) | $49.30B | $45.60B | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $2.30B | (m) | (m) | $2.60B | $2.70B | $2.10B | $3.00B | $2.70B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $1.41B | $39.97B | (m) | (m) | (m) | (m) | (m) | (m) | $41.40B | $37.70B | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $1.43B | $33.97B | (m) | (m) | (m) | (m) | (m) | (m) | $35.40B | $31.30B | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $1.36B | $33.48B | (m) | (m) | (m) | (m) | (m) | (m) | $34.80B | $30.60B | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $2.50B | $2.65B | $34.46B | (m) | (m) | (m) | (m) | (m) | (m) | $37.10B | $32.60B | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $2.60B | $2.20B | $1.50B | $2.10B | $1.70B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $3.15B | $34.98B | (m) | (m) | (m) | (m) | (m) | (m) | $38.10B | $35.20B | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $3.07B | $34.72B | (m) | (m) | (m) | (m) | (m) | (m) | $37.80B | $33.50B | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $3.08B | $31.14B | (m) | (m) | (m) | (m) | (m) | (m) | $34.20B | $30.40B | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.30B | $1.37B | $33.68B | (m) | (m) | (m) | (m) | (m) | (m) | $35.10B | $32.00B | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $1.40B | $2.50B | $2.20B | $1.50B | $2.10B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $887.00M | $33.97B | (m) | (m) | (m) | (m) | (m) | (m) | $34.90B | $29.50B | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $2.84B | $34.07B | (m) | (m) | (m) | (m) | (m) | (m) | $36.90B | $34.00B | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $2.67B | $28.07B | (m) | (m) | (m) | (m) | (m) | (m) | $30.70B | $28.20B | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.70B | $1.95B | $28.75B | (m) | (m) | (m) | (m) | (m) | (m) | $30.70B | $26.70B | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $1.70B | $1.30B | $2.50B | $2.20B | $1.50B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $1.94B | $28.48B | (m) | (m) | (m) | (m) | (m) | (m) | $30.40B | $25.90B | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $2.98B | $28.68B | (m) | (m) | (m) | (m) | (m) | (m) | $31.70B | $29.00B | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $1.21B | $30.59B | (m) | (m) | (m) | (m) | (m) | (m) | $31.80B | $31.70B | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $2.30B | $2.41B | $30.69B | (m) | (m) | (m) | (m) | (m) | (m) | $33.10B | $35.70B | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $2.30B | $1.70B | $1.30B | $2.50B | $2.30B | $6.00B | (m) | (m) | (m) | (m) | $8.00B | (m) | (m) |
| 2021-09-30 | (m) | $3.53B | $22.91B | (m) | (m) | (m) | (m) | (m) | (m) | $26.40B | $29.10B | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $2.49B | $24.03B | (m) | (m) | (m) | (m) | (m) | (m) | $26.50B | $29.50B | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $7.25B | $24.00B | (m) | (m) | (m) | (m) | (m) | (m) | $31.30B | $33.50B | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $2.30B | $6.43B | $25.36B | (m) | (m) | (m) | (m) | (m) | (m) | $31.80B | $36.00B | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $2.30B | $2.30B | $1.70B | $1.40B | $2.50B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $2.42B | $26.32B | (m) | (m) | (m) | (m) | (m) | (m) | $28.70B | $32.60B | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.50B | (m) | (m) |
| 2020-06-30 | (m) | $4.72B | $26.16B | (m) | (m) | (m) | (m) | (m) | (m) | $30.90B | $34.50B | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $6.36B | $21.64B | (m) | (m) | (m) | (m) | (m) | (m) | $28.00B | $30.60B | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $1.90B | $3.61B | $22.74B | (m) | (m) | (m) | (m) | (m) | (m) | $26.30B | $28.80B | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | $1.90B | $2.30B | $2.30B | $1.70B | $1.30B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $3.41B | $22.68B | (m) | (m) | (m) | (m) | (m) | (m) | $26.10B | $28.70B | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $3.82B | $22.77B | (m) | (m) | (m) | (m) | (m) | (m) | $26.60B | $28.60B | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00B | (m) | (m) |
| 2019-03-31 | (m) | $3.17B | $22.72B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.10B | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $5.31B | $19.81B | (m) | (m) | (m) | (m) | (m) | (m) | $25.10B | $25.60B | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $0.00 | $1.90B | $2.30B | $2.20B | $1.70B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $3.66B | $19.94B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $24.00B | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $3.38B | $19.96B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $23.90B | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $2.06B | $21.50B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $24.30B | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $3.00B | $3.06B | $21.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.60B | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $3.00B | $1.30B | $1.90B | $2.30B | $2.20B | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $585.00M | (m) |
| 2017-09-30 | (m) | $5.16B | $21.84B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $28.30B | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $3.18B | $21.71B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $26.00B | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $5.04B | $23.44B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $29.30B | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $300.00M | $568.00M | $24.27B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.70B | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $301.00M | $3.00B | $1.30B | $1.90B | $2.20B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.00B | (m) | (m) | (m) |
| 2016-09-30 | (m) | $1.49B | $23.66B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.00B | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $644.00M | $23.64B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $26.20B | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $2.11B | $23.66B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.20B | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $2.30B | $2.58B | $23.83B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.00B | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | $2.40B | $317.00M | $3.00B | $1.30B | $2.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $2.54B | $24.12B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.20B | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $2.48B | $24.07B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $26.90B | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $4.73B | $25.51B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $31.60B | (m) | (m) | (m) | (m) | (m) |
| 2015-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $8.00B | (m) | (m) |
| 2014-12-31 | $1.00B | $2.70B | $18.70B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.50B | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | $1.00B | $2.40B | $19.00M | $3.00B | $1.30B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.00B | (m) |
| 2014-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.50B | (m) | $1.80B | (m) |
| 2014-09-30 | (m) | $9.28B | $18.57B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $29.00B | (m) | (m) | (m) | (m) | (m) |
| 2014-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $4.48B | $18.59B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $24.20B | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $8.56B | $19.59B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $28.90B | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $2.10B | $4.52B | $20.54B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.50B | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $2.10B | $2.10B | $2.40B | $1.10B | $3.00B | $4.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | $3.98B | $22.65B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $27.30B | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $5.58B | $22.53B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $29.00B | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $4.74B | $16.09B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.80B | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $1.80B | $4.32B | $16.25B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.80B | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $1.80B | $2.10B | $2.10B | $884.00M | $1.10B | $4.00B | (m) | (m) | (m) | (m) | (m) | (m) | 0.10% |
| 2012-09-30 | (m) | $2.03B | $17.57B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $22.10B | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $3.92B | $15.06B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $21.20B | (m) | (m) | (m) | (m) | (m) |
| 2012-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $2.93B | $15.23B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $20.00B | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $1.99B | $15.53B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $19.50B | (m) | (m) | (m) | (m) | 0.20% |
| 2011-12-31 | (m) | (m) | (m) | $24.00M | $1.80B | $2.10B | $2.10B | $893.00B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $2.46B | $15.69B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $19.70B | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $2.52B | $15.78B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $18.80B | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $2.20B | $15.64B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $18.30B | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $2.40B | $15.48B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $18.70B | (m) | (m) | (m) | (m) | 0.40% |
| 2010-09-30 | (m) | $4.12B | $14.03B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $19.50B | $18.10B | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | $4.15B | $13.84B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $19.00B | $18.00B | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | $3.82B | $15.28B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.38B | $16.09B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $17.70B | (m) | (m) | (m) | (m) | 0.00% |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $17.50B | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | $185.00M | $8.03B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | $261.00M | $7.91B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $2.30B | $3.94B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |